See All Slides - tctmd.com

Slides

Presentation TCT 2023

QFR in the real world - how I use QFR and how QFR changes my procedure approach

Presenter: Yuhei Kobayashi

October 25, 2023

Presentation TCT 2023

How Surgeons Do Surgical Annuloplasty and How Can It Be Adopted to Transcatheter Technologies?

Presenter: Paolo Denti

October 25, 2023

Presentation TCT 2023

TCT 824: IVUS guided PTCA to LM-LAD-Ramus- LCX trifurcation with minimal crush technique

Presenter: Nishith Chandra

October 25, 2023

Presentation TCT 2023

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Presenter: Michael Savage

October 25, 2023

Presentation TCT 2023

Position 1: Initial SAVR With Mechanical Valve

Presenter: Katherine Harrington

October 25, 2023

Presentation TCT 2023

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Presenter: Nir Uriel

October 25, 2023

Presentation TCT 2023

Complications With Catheter Therapy

Presenter: Sonal Pruthi

October 25, 2023

Presentation TCT 2023

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

Presenter: Mehdi Shishehbor

October 25, 2023

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

Presentation TCT 2023

TCT 164: TRILUMINATE eligibility criteria in real-world patients receiving tricuspid valve transcatheter edge-to-edge repair

Presenter: Lukas Stolz

October 25, 2023

Advertisement

Slides

QFR in the real world - how I use QFR and how QFR changes my procedure approach

How Surgeons Do Surgical Annuloplasty and How Can It Be Adopted to Transcatheter Technologies?

TCT 824: IVUS guided PTCA to LM-LAD-Ramus- LCX trifurcation with minimal crush technique

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Position 1: Initial SAVR With Mechanical Valve

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Complications With Catheter Therapy

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

TCT 164: TRILUMINATE eligibility criteria in real-world patients receiving tricuspid valve transcatheter edge-to-edge repair

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content